330 related articles for article (PubMed ID: 25943786)
21. Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study.
Parada LA; Limon J; Iliszko M; Czauderna P; Gisselsson D; Höglund M; Kullendorff CM; Wiebe T; Mertens F; Johansson B
Med Pediatr Oncol; 2000 Mar; 34(3):165-70. PubMed ID: 10696121
[TBL] [Abstract][Full Text] [Related]
22. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.
Wong N; Lam WC; Lai PB; Pang E; Lau WY; Johnson PJ
Am J Pathol; 2001 Aug; 159(2):465-71. PubMed ID: 11485905
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced chromosome aberrations in human euchromatic (17cen-p53) and heterochromatic (1cen-1q12) regions.
Puerto S; Ramírez MJ; Marcos R; Creus A; Surrallés J
Mutagenesis; 2001 Jul; 16(4):291-6. PubMed ID: 11420395
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of abnormalities of chromosomes 1 and 13 in multiple myeloma.
Nakagawa Y; Sawanobori M; Amaya H; Matsuda I; Inoue Y; Suzuki K; Hashimoto S; Kanno K
Acta Haematol; 2003; 109(3):129-36. PubMed ID: 12714822
[TBL] [Abstract][Full Text] [Related]
25. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
26. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.
Kosztolányi S; Kiss R; Atanesyan L; Gángó A; de Groot K; Steenkamer M; Jáksó P; Matolcsy A; Kajtár B; Pajor L; Szuhai K; Savola S; Bödör C; Alpár D
J Mol Diagn; 2018 Nov; 20(6):777-788. PubMed ID: 30096382
[TBL] [Abstract][Full Text] [Related]
27. Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.
Nahi H; Våtsveen TK; Lund J; Heeg BM; Preiss B; Alici E; Møller MB; Wader KF; Møller HE; Grøseth LA; Østergaard B; Dai HY; Holmberg E; Gahrton G; Waage A; Abildgaard N
Eur J Haematol; 2016 Jan; 96(1):46-54. PubMed ID: 25779478
[TBL] [Abstract][Full Text] [Related]
28. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
Neben K; Jauch A; Hielscher T; Hillengass J; Lehners N; Seckinger A; Granzow M; Raab MS; Ho AD; Goldschmidt H; Hose D
J Clin Oncol; 2013 Dec; 31(34):4325-32. PubMed ID: 24145347
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.
Fonseca R; Van Wier SA; Chng WJ; Ketterling R; Lacy MQ; Dispenzieri A; Bergsagel PL; Rajkumar SV; Greipp PR; Litzow MR; Price-Troska T; Henderson KJ; Ahmann GJ; Gertz MA
Leukemia; 2006 Nov; 20(11):2034-40. PubMed ID: 17024118
[TBL] [Abstract][Full Text] [Related]
30. [Research Advances in Multiple Myeloma with Chromosome 1q21 Amplification].
Wang C; Hu R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):649-652. PubMed ID: 35400366
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of chromosome 1 aberrations in patients with multiple myeloma using cIg-FISH method and its significance].
Yang RF; Li CM; Qiu HR; Lu H; Wu HX; Xu JR; Li JY; Chen LJ
Zhonghua Xue Ye Xue Za Zhi; 2010 Dec; 31(12):804-8. PubMed ID: 21223735
[TBL] [Abstract][Full Text] [Related]
32. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
[TBL] [Abstract][Full Text] [Related]
33. Unusual presentation of multiple myeloma with "jumping translocation" involving 1q21. A case report and review of the literature.
Keung YK; Yung C; Wong JW; Shah F; Cobos E; Tonk V
Cancer Genet Cytogenet; 1998 Oct; 106(2):135-9. PubMed ID: 9797778
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21.
Tomlinson GE; Douglass EC; Pollock BH; Finegold MJ; Schneider NR
Genes Chromosomes Cancer; 2005 Oct; 44(2):177-84. PubMed ID: 15981236
[TBL] [Abstract][Full Text] [Related]
35. Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.
Burroughs Garcìa J; Eufemiese RA; Storti P; Sammarelli G; Craviotto L; Todaro G; Toscani D; Marchica V; Giuliani N
Cells; 2021 Jun; 10(6):. PubMed ID: 34205916
[TBL] [Abstract][Full Text] [Related]
36. Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
Grzasko N; Hus M; Pluta A; Jurczyszyn A; Walter-Croneck A; Morawska M; Chocholska S; Hajek R; Dmoszynska A
Hematol Oncol; 2013 Mar; 31(1):41-8. PubMed ID: 22674819
[TBL] [Abstract][Full Text] [Related]
37. Supernumerary der(1) marker chromosome derived from a ring chromosome 1 which has retained the original centromere and euchromatin from 1q21.1 --> q21.3 with substantial loss of 1q12 heterochromatin in a female with dysmorphic features and psychomotoric developmental delay.
Barbi G; Spaich Ch; Adolph S; Rossier E; Kehrer-Sawatzki H
Am J Med Genet A; 2005 Feb; 132A(4):419-24. PubMed ID: 15633178
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal defects in multiple myeloma.
Clarke SE; Fuller KA; Erber WN
Blood Rev; 2024 Mar; 64():101168. PubMed ID: 38212176
[TBL] [Abstract][Full Text] [Related]
39. 1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma.
Fournier A; McLeer-Florin A; Lefebvre C; Duley S; Barki L; Ribeyron J; Alboukadel K; Hamaidia S; Granjon A; Gressin R; Lajmanovich A; Bonnefoix T; Chauvelier S; Debernardi A; Rousseaux S; de Fraipont F; Figeac M; Kerckaert JP; De Vos J; Usson Y; Delaval K; Grichine A; Vourc'h C; Khochbin S; Feil R; Leroux D; Callanan MB
EMBO Mol Med; 2010 May; 2(5):159-71. PubMed ID: 20432501
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.
Stella F; Pedrazzini E; Baialardo E; Fantl DB; Schutz N; Slavutsky I
Blood Cells Mol Dis; 2014 Sep; 53(3):110-7. PubMed ID: 24973170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
